GKOS

NYSE HEALTHCARE

Glaukos Corp

$182.37

$4.10 (+2.30%)

Live quote

52w: $73.16 – $191.62

Loading chart…

P/E Ratio—

P/B Ratio15.41

EV/EBITDA—

Debt/Equity—

ROE-27.50%

ROIC—

Revenue Growth32.33%

Gross Margin55.72%

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, is focused on developing new therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company is headquartered in San Clemente, California.

Own GKOS? Track it here.

Create a free account to add GKOS to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account